Search

everythinglearnresearchcommunity

for

Search:↓

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

tSVF is effective for treating inflammation-related conditions, with centrifugation being the best method for isolation.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

A protein called FERONIA helps control root hair growth in response to cold and low nitrogen by activating nutrient-sensing pathways in a plant called Arabidopsis.

The type 3 IP3 receptor is important for controlling hair loss and growth.

GLI2 increases follistatin production in human skin cells.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.

TGF-β1 and 2 may play a role in hair loss in AGA.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Combining FTSC with TSN6 peptide greatly improves wound healing.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

The proteins transthyretin and megalin are more present in the growth phase of hair, suggesting they might affect hair health and growth.

Sheep hair follicle transglutaminases are calcium-dependent.

TLR2 is crucial for hair growth and regeneration, and boosting it can help prevent hair loss.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Temporal triangular alopecia is a harmless, non-progressive hair loss condition.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Activating TRPV3 stops human hair growth.

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

Trps1 is essential for proper hair follicle development.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.